Products - Osteoporosis | Topic | NICE

Showing 5 products

Date | Title

New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Osteoporosis: risk assessment, treatment, and fragility fracture prevention (update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
29 July 2026
Abaloparatide for treating idiopathic or hypogonadal osteoporosis in men [ID4059]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Osteoporosis
Status:
In development
Expected publication date:
TBC
Medicines for treating osteoporosis and reducing the risk of fragility fractures (review of TA160, TA161, TA204, TA464, TA791, TA991) [ID6689]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Setrusumab for treating osteogenesis imperfecta [ID6730]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC